Join
This site is intended for healthcare professionals
1
Early DORIS Remission in SLE
2
EMJ Rheumatology 13 [Supplement 1] 2026
3
An FDA Approval for Certain Patients with Endometrial Cancer
4
Is it Time to Label ‘At Risk of Rheumatoid Arthritis’ a Disease?
5
HRRm Testing in mCRPC
Allergy and Immunology Misinformation Unchallenged on Social Media
Retinal Artery Occlusion Linked to Higher Cardiovascular Risk
Acne Scar Treatment: CO₂ Laser Compared with Microneedling
First Drug to Delay Onset of Type 1 Diabetes to Be Rolled Out on NHS
MHRA issues warning against promoting unlicensed drugs
EMJ’s latest Flagship Journal
IBD Unclassified Diagnosis Remains Stable Long Term
Psychosocial Screening Tools Could Improve Cancer Care
Novel CAR T Cell Targets Identified for AML
Novel TREM2 Feedback Loop Identified as Driver of Liver Fibrosis
Digital Human Proteome Map Opens New Pathways for Cancer Therapy
How Performance Metrics Influence Clinical Decisions
Valacyclovir in cCMV Linked to Fewer Fetal Brain Lesions on MRI
Renal Risk Tied to GI Severity in Paediatric IgA Vasculitis
Women with Parkinson’s More Prone to Alzheimer’s Pathology: EAN 2026
AMJ Oncology 3 [Supplement 4] 2026
Bronchiectasis Outcomes Worsen with Diabetes
Artery Stiffness Test Beats SCORE2 in Autoimmune Rheumatic Diseases
Larger Prostates Reduce Cancer Detection in Fusion Biopsy